E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 8/7/2013 in the Prospect News Convertibles Daily.

New Issue: Medidata sells $250 million five-year convertibles to yield 1%, up 35%

By Stephanie N. Rotondo

Phoenix, Aug. 7 - Medidata Solutions Inc. sold $250 million five-year convertible senior notes at par on Wednesday to yield 1% with an initial conversion premium of 35%, according to a company press release.

The company announced the deal on Monday, proposing to sell $200 million of the notes. A trader said on Tuesday that the deal had been upsized.

There is a $37.5 million over-allotment option.

The notes can become convertible prior to Feb. 1, 2018 under certain circumstances. After that date, holders can convert the notes at any time.

The initial conversion rate is equivalent to 8.6143 shares of common stock per $1,000 of notes, which results in a conversion price of $116.09 per share.

Proceeds will be used for working capital and other general corporate purposes, including to fund possible acquisitions of, or investments in, complementary businesses, products, services, technologies and capital expenditures.

Medidata is a New York-based company that provides cloud-based clinical development solutions for life sciences organizations.

Issuer:Medidata Solutions Inc.
Securities:Convertible senior notes
Amount:$250 million, increased from $200 million
Greenshoe:$37.5 million
Maturity:Aug. 1, 2018
Coupon:1%
Price:Par of $1,000
Yield:1%
Call options:Prior to Feb. 1, 2018 under certain circumstances or at any time thereafter
Conversion premium:35%
Conversion price:$116.09 per share
Conversion ratio:8.6143 common shares per $1,000 of notes
Pricing date:Aug. 7
Settlement date:Aug. 12
Stock symbol:Nasdaq: MDSO
Stock reference price:$85.99 at close Aug. 6

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.